Pain Management for Post-Total Knee Replacement

Introduction to Pain Management

The American College of Physicians and the American Academy of Orthopaedic Surgeons recommend a multimodal approach to pain management, including acetaminophen, NSAIDs, and duloxetine, and against using strong opioids for OA pain management 1, 2
The American College of Rheumatology conditionally recommends duloxetine for knee OA 2

Acetaminophen is recommended as first-line therapy, with dosing at 1g every 8 hours (not exceeding 3g daily), and can be given intravenously initially until gut function recovers 1, 2
NSAIDs are superior to acetaminophen for moderate-to-severe OA pain, but should be used with caution due to potential renal effects post-surgery, and topical NSAIDs are recommended for knee OA with fewer systemic effects 1, 3
Duloxetine is conditionally recommended for knee OA, with dosing starting at 30mg daily and increasing to 60mg daily, and is particularly effective for neuropathic pain components 1, 2
Pregabalin (600mg) given 2 hours before surgery improves pain scores, reduces opioid requirements, and postoperative nausea/vomiting 3
Dexmedetomidine reduces opioid requirements, is associated with lower incidence of postoperative delirium, and may reduce acute kidney injury after cardiac surgery 3

Elderly patients should use lower doses of all medications, particularly duloxetine and NSAIDs 4, 5, 6, 7
Patients with renal impairment should avoid NSAIDs and use reduced doses of acetaminophen, and tramadol dosing interval should be increased to 12 hours, with a maximum daily dose of 200 mg 7, 8
Patients with hepatic impairment (cirrhosis) should be dosed at 50 mg every 12 hours, with bioavailability potentially increasing 2-3 fold, and may require lower doses of tramadol 7, 8
Patients with a history of seizures should avoid tramadol as it lowers seizure threshold, with a high strength of evidence 9

The immediate post-operative period (0-48 hours) should include IV acetaminophen 1g every 8 hours and duloxetine 30mg daily if neuropathic pain features are present 1
The early recovery phase (48 hours-2 weeks) should involve transitioning to oral acetaminophen, adding topical or oral NSAIDs if no contraindications, and increasing duloxetine to 60mg daily if needed and tolerated 1, 2
The rehabilitation phase (2 weeks onward) should include continuing acetaminophen and NSAIDs as needed, considering intra-articular corticosteroid injection for breakthrough pain, and tapering duloxetine slowly when pain is adequately controlled 1, 2

Elevation, ice, and appropriate physical therapy can be used as non-pharmacological measures to manage post-surgical pain, as recommended by the British Journal of Anaesthesia 10

Tramadol should be considered as a second or third-line treatment option for arthritis and chronic joint pain, following a treatment algorithm that starts with non-pharmacologic interventions and NSAIDs or acetaminophen, with a moderate strength of evidence 2, 11
Tramadol provides modest benefits in osteoarthritis pain management, with clinical trials demonstrating some symptomatic efficacy, though the benefits are relatively small, with a moderate strength of evidence 2, 11
The maximum daily dose of tramadol should not exceed 400 mg, with a recommended starting dose of 50-100 mg orally every 4-6 hours as needed, according to the Journal of the National Comprehensive Cancer Network, the Mayo Clinic Proceedings, and the American Society of Clinical Oncology 4, 5, 6, 12
Tramadol should be used with caution or avoided in patients taking serotonergic medications (SSRIs, MAOIs, TCAs) due to the risk of serotonin syndrome, as recommended by the British Journal of Cancer 13
Patients should be monitored for signs of physical dependence with prolonged use, and concomitant use with alcohol should be avoided, as recommended by the Journal of the National Comprehensive Cancer Network 14
Tramadol administration should be monitored for adverse effects, including respiratory depression, hypotension, dizziness, and nausea, with vital signs assessed before, during, and after administration, as recommended by the Mayo Clinic Proceedings and the National Comprehensive Cancer Network 4, 5, 6